Some GLP-1 and related medications are approved for chronic weight management in eligible adults without diabetes
Your medical provider may schedule an additional appointment and further testing to look into your: Overall bloodwork Gut health Cortisol levels Hormone levels Cholesterol Insulin resistance Now, with a complete understanding of your condition, we can identify problem areas such as nutrient deficiencies, hormone imbalances, and metabolic health issues that may be preventing weight loss
FOR FATIGUE SOURCE: DailyMed
7 But Pendulum also uses proprietary strains, so the research on them is currently limited to studies funded by Pendulum itself
One sample report involving a patient, provided by Ro, showed a summary of the insurance coverage, supply availability and estimated copay for each drug, including Wegovy, Ozempic, Eli Lilly's weight loss injection Zepbound and compounded semaglutide, the active ingredient in Novo Nordisk's GLP-1s
On February 6, 2026, the US Food and Drug Administration (FDA) announced its intent to take action against compounded GLP-1 medications